{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:10Z","timestamp":1792112230823,"version":"4.4.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020252","name":"CRUK Lung Cancer Centre of Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"The Mark Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004437","name":"European Association For Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016916","name":"The Royal Marsden Cancer Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006433","name":"Barcelona Supercomputing Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012621","name":"NIHR University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.immuni.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:22:20Z","timestamp":1775665340000},"page":"1398-1421.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-4887","authenticated-orcid":false,"given":"Roberto","family":"Vendramin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanila","family":"Fernandez Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danwen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Ligammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Bartok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.T.","family":"Sng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Bhamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc","family":"Farriol-Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Karagianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellus","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krijn K.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon Weng-Kit","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Galvez-Cancino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Vlckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Surinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodriguez-Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"McGranahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy G.","family":"Carlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gr\u00f6nroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Reading","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yardena","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.02.005_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7918","article-title":"Neoantigen quality, not quantity","volume":"11","author":"McGranahan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/1878-0261.13483","article-title":"Neoantigens in cancer immunotherapy: quantity vs. quality","volume":"17","author":"Wolf","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.immuni.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science."},{"key":"10.1016\/j.immuni.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.immuni.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","article-title":"Tumor mutational burden as a predictive biomarker in solid tumors","volume":"10","author":"Sha","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","article-title":"Improved prediction of immune checkpoint blockade efficacy across multiple cancer types","volume":"40","author":"Chowell","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor Mutational Burden and Response Rate to PD-1 Inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.immuni.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3560","article-title":"Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance","volume":"9","author":"Roh","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"cancer cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s43018-025-00979-2","article-title":"Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer","volume":"6","author":"Apavaloaei","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib21","article-title":"T Cell Dysfunction and Exhaustion in Cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008645","article-title":"Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes","volume":"12","author":"Levin","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm3454","article-title":"NMD: A multifaceted response to premature translational termination","volume":"13","author":"Kervestin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(17)30516-8","article-title":"Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis","volume":"18","author":"Turajlic","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41588-019-0517-5","article-title":"The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy","volume":"51","author":"Lindeboom","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17526-5","article-title":"Escape from nonsense-mediated decay associates with anti-tumor immunogenicity","volume":"11","author":"Litchfield","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.1298","article-title":"Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens","volume":"93","author":"Linnebacher","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib30","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2013.02.035","article-title":"Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: Frameshift peptides for treating MSI+ blood cancers","volume":"49","author":"Maletzki","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrm4063","article-title":"Nonsense-mediated mRNA decay: An intricate machinery that shapes transcriptomes","volume":"16","author":"Lykke-Andersen","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","article-title":"Nonsense-mediated RNA decay: an emerging modulator of malignancy","volume":"22","author":"Tan","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib36","first-page":"453","article-title":"When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells","volume":"1","author":"Maquat","year":"1995","journal-title":"RNA"},{"key":"10.1016\/j.immuni.2026.02.005_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007467","article-title":"Evolution of the nonsense-mediated decay pathway is associated with decreased cytolytic immune infiltration","volume":"15","author":"Zhao","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15943","article-title":"A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay","volume":"8","author":"Hu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ng.3664","article-title":"The rules and impact of nonsense-mediated mRNA decay in human cancers","volume":"48","author":"Lindeboom","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","article-title":"To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases","volume":"37","author":"Supek","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","article-title":"Nonsense-mediated mRNA decay in humans at a glance","volume":"129","author":"Kurosaki","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.immuni.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1534\/g3.117.300254","article-title":"The substrates of nonsense-mediated mRNA decay in Caenorhabditis elegans","volume":"8","author":"Muir","year":"2018","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.immuni.2026.02.005_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/biomedicines10010141","article-title":"Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism","volume":"10","author":"Lejeune","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.immuni.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrc4018","article-title":"Directly targeting transcriptional dysregulation in cancer","volume":"15","author":"Gonda","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional Addiction in Cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","article-title":"RNA splicing dysregulation and the hallmarks of cancer","volume":"23","author":"Bradley","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-024-08552-0","article-title":"Tumour-wide RNA splicing aberrations generate actionable public neoantigens","volume":"639","author":"Kwok","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5516","article-title":"Noncoding regions are the main source of targetable tumor-specific antigens","volume":"10","author":"Laumont","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib50","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/2159-8290.CD-20-0555","article-title":"Splicing patterns in sf3b-mutated uveal melanoma generate shared immunogenic tumor-specific neoepitopes","volume":"11","author":"Bigot","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.02.005_bib51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","article-title":"Anti-tumour immunity induces aberrant peptide presentation in melanoma","volume":"590","author":"Bartok","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ccell.2025.03.003","article-title":"Translation dysregulation in cancer as a source for targetable antigens","volume":"43","author":"Weller","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib53","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","article-title":"Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer","volume":"40","author":"Ouspenskaia","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.02.005_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk3487","article-title":"Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition","volume":"388","author":"Ely","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib56","doi-asserted-by":"crossref","DOI":"10.4161\/onci.25374","article-title":"High frequency of T cells specific for cryptic epitopes in melanoma patients","volume":"2","author":"Andersen","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.immuni.2026.02.005_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003404","article-title":"Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors","volume":"9","author":"Marcu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005651","article-title":"T cells of colorectal cancer patients\u2019 stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells","volume":"10","author":"Schwarz","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature08999","article-title":"Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay","volume":"465","author":"Pastor","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01679-6","article-title":"IL-6\/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction","volume":"21","author":"Meraviglia-Crivelli","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/genes14020357","article-title":"Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis","volume":"14","author":"Nagar","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.immuni.2026.02.005_bib62","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107895","article-title":"Ribosome Recycling by ABCE1 Links Lysosomal Function and Iron Homeostasis to 3\u2032 UTR-Directed Regulation and Nonsense-Mediated Decay","volume":"32","author":"Zhu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.02.005_bib64","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1101\/gad.913001","article-title":"Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay","volume":"15","author":"Yamashita","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2026.02.005_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.1389006","article-title":"Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay","volume":"20","author":"Kashima","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2026.02.005_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/gtc.12033","article-title":"Role of SMG-1-mediated Upf1 phosphorylation in mammalian nonsense-mediated mRNA decay","volume":"18","author":"Yamashita","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.immuni.2026.02.005_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33178","article-title":"ICE1 promotes the link between splicing and nonsense-mediated mRNA decay","volume":"7","author":"Baird","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.02.005_bib68","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.bmcl.2012.08.107","article-title":"Identification of pyrimidine derivatives as hSMG-1 inhibitors","volume":"22","author":"Gopalsamy","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.immuni.2026.02.005_bib69","first-page":"8838","article-title":"Translation-dependent unwinding of stem-loops by UPF1 licenses Regnase-1 to degrade inflammatory mRNAs","volume":"47","author":"Mino","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72353","article-title":"Cryo-em reconstructions of inhibitor-bound smg1 kinase reveal an autoinhibitory state dependent on smg8","volume":"10","author":"Langer","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.02.005_bib71","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/0008-5472.CAN-20-4016","article-title":"Nonsense-mediated RNA decay is a unique vulnerability of cancer cells harboring sf3b1 or u2af1 mutations","volume":"81","author":"Cheruiyot","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"MTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1073\/pnas.0136770100","article-title":"Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans","volume":"100","author":"Lewis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.02.005_bib76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","article-title":"Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery","volume":"122","author":"Powley","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib77","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.immuni.2026.02.005_bib79","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41571-024-00943-6","article-title":"Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response","volume":"21","author":"Williams","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.immuni.2026.02.005_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-5-r35","article-title":"Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns","volume":"13","author":"Weischenfeldt","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib81","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1541-7786.MCR-16-0459","article-title":"The landscape of isoform switches in human cancers","volume":"15","author":"Vitting-Seerup","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-021-02439-3","article-title":"Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells","volume":"22","author":"Karousis","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib83","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1168978","article-title":"Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling","volume":"324","author":"Ingolia","year":"2009","journal-title":"Science."},{"key":"10.1016\/j.immuni.2026.02.005_bib84","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.aay0262","article-title":"Pervasive functional translation of noncanonical human open reading frames","volume":"367","author":"Chen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib74","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.02.005_bib75","article-title":"Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib85","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.immuni.2026.02.005_bib86","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib87","article-title":"PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?","volume":"7","author":"Simon","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.immuni.2026.02.005_bib88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/imr.12657","article-title":"The function and dysfunction of memory CD8+ T cells in tumor immunity","volume":"283","author":"Reading","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2026.02.005_bib89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: Function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.02.005_bib90","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","article-title":"Emerging concepts in tissue-resident T cells: Lessons from humans","volume":"36","author":"Thome","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2026.02.005_bib91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/cancers8030036","article-title":"Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy","volume":"8","author":"Golubovskaya","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.immuni.2026.02.005_bib92","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","article-title":"Understanding Subset Diversity in T Cell Memory","volume":"48","author":"Jameson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.02.005_bib93","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib94","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95952","article-title":"Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape","volume":"13","author":"Cook","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.02.005_bib95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s43018-019-0007-9","article-title":"Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade","volume":"1","author":"Ajona","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215508","article-title":"Neoantigen dendritic cell vaccination combined with anti-cd38 and cpg elicits anti-tumor immunity against the immune checkpoint therapy-resistant murine lung cancer cell line llc1","volume":"13","author":"Sun","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.immuni.2026.02.005_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8780","article-title":"Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers","volume":"8","author":"Mugarza","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.immuni.2026.02.005_bib98","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1158\/0008-5472.CAN-22-0325","article-title":"An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations","volume":"82","author":"Boumelha","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/2326-6066.CIR-16-0114","article-title":"Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery","volume":"5","author":"Mosely","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib100","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib101","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib102","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nmeth.3144","article-title":"Proteogenomics: Concepts, applications and computational strategies","volume":"11","author":"Nesvizhskii","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.02.005_bib103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1074-7613(00)80067-9","article-title":"Presentation of out-of-frame peptide\/MHC class I complexes by a novel translation initiation mechanism","volume":"10","author":"Malarkannan","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.02.005_bib104","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nprot.2014.064","article-title":"Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells","volume":"9","author":"W\u00f6lfl","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib105","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s41596-019-0170-6","article-title":"Induction of neoantigen-reactive T cells from healthy donors","volume":"14","author":"Ali","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib106","doi-asserted-by":"crossref","first-page":"E10702","DOI":"10.1073\/pnas.1810653115","article-title":"Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules","volume":"115","author":"Bethune","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.immuni.2026.02.005_bib107","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","article-title":"The evolution of lung cancer and impact of subclonal selection in TRACERx","volume":"616","author":"Frankell","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib108","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ccell.2025.06.012","article-title":"Subclonal immune evasion in non-small cell lung cancer","volume":"43","author":"Dijkstra","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib109","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/0008-5472.CAN-08-2926","article-title":"A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design","volume":"69","author":"Ebert","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib110","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.27792","article-title":"NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability","volume":"132","author":"Sommermeyer","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib111","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.immuni.2026.02.005_bib112","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41090","article-title":"Rejection of immunogenic tumor clones is limited by clonal fraction","volume":"7","author":"Gejman","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.02.005_bib113","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib114","doi-asserted-by":"crossref","first-page":"E285","DOI":"10.1073\/pnas.1215696110","article-title":"Smg1 haploinsufficiency predisposes to tumor formation and inflammation","volume":"110","author":"Roberts","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.02.005_bib115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04996","article-title":"A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy","volume":"4","author":"Feng","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2026.02.005_bib116","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuron.2019.08.027","article-title":"Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response","volume":"104","author":"Johnson","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.immuni.2026.02.005_bib117","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.20107","article-title":"Inhibition of Nonsense-Mediated mRNA Decay Rescues the Phenotype in Ullrich\u2019s Disease","volume":"55","author":"Usuki","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.immuni.2026.02.005_bib118","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/acsmedchemlett.6b00006","article-title":"Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations","volume":"7","author":"Sabbavarapu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.immuni.2026.02.005_bib119","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-7-58","article-title":"Rescue of nonsense mutations by amlexanox in human cells","volume":"7","author":"Gonzalez-Hilarion","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.immuni.2026.02.005_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102389","article-title":"NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes","volume":"24","author":"Becker","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.immuni.2026.02.005_bib121","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.14694\/EdBook_AM.2014.34.e57","article-title":"The Rising Incidence of Second Cancers: Patterns of Occurrence and Identification of Risk Factors for Children and Adults","volume":"34","author":"Morton","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.immuni.2026.02.005_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24858-3","article-title":"The evolution of hematopoietic cells under cancer therapy","volume":"12","author":"Pich","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib123","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/2159-8290.CD-23-1186","article-title":"Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues","volume":"14","author":"S\u00e1nchez-Guix\u00e9","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2026.02.005_bib124","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180390","article-title":"Review of risk factors of secondary cancers among cancer survivors","volume":"92","author":"Demoor-Goldschmidt","year":"2019","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.immuni.2026.02.005_bib125","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.immuni.2026.02.005_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35673-0","article-title":"Using Frameshift Peptide Arrays for Cancer Neo-Antigens Screening","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2026.02.005_bib127","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2026.02.005_bib128","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-8-8","article-title":"A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma","volume":"8","author":"Rahma","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.immuni.2026.02.005_bib129","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1158\/1078-0432.CCR-19-3517","article-title":"A frameshift peptide neoantigen-based vaccine for mismatch repair-deficient cancers: A phase I\/IIa clinical trial","volume":"26","author":"Kloor","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib130","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2020.11.004","article-title":"Shared immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors","volume":"183","author":"Roudko","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib131","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1053\/j.gastro.2021.06.073","article-title":"Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model","volume":"161","author":"Gebert","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.immuni.2026.02.005_bib132","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-024-08507-5","article-title":"A neoantigen vaccine generates antitumour immunity in renal cell carcinoma","volume":"639","author":"Braun","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib133","article-title":"Making In Vitro Tumor Models Whole Again","volume":"12","author":"Wu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.immuni.2026.02.005_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100116","article-title":"MS-based HLA-II peptidomics combined with multiomics will aid the development of future immunotherapies","volume":"20","author":"Taylor","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.immuni.2026.02.005_bib135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases - The major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2026.02.005_bib136","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib137","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41588-024-01878-5","article-title":"Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules","volume":"56","author":"Toledano","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib138","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib177","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2026.02.005_bib182","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/jvi.69.12.7430-7436.1995","article-title":"High-titer packaging cells producing recombinant retroviruses resistant to human serum","volume":"69","author":"Cosset","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2026.02.005_bib183","article-title":"Retroviral vector production","volume":"80","author":"Miller","year":"2014","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib176","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.02.005_bib174","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2326-6066.CIR-19-0886","article-title":"Identification of the cryptic HLA-I immunopeptidome","volume":"8","author":"Erhard","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib184","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nmeth.4256","article-title":"MSFragger: Ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics","volume":"14","author":"Kong","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.02.005_bib185","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46408-3","article-title":"Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides","volume":"15","author":"Ferreira","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib186","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib142","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ng.3036","article-title":"Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications","volume":"46","author":"Rimmer","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.immuni.2026.02.005_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003118","article-title":"Software for Computing and Annotating Genomic Ranges","volume":"9","author":"Lawrence","year":"2013","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib145","doi-asserted-by":"crossref","first-page":"D1188","DOI":"10.1093\/nar\/gkac1072","article-title":"The UCSC Genome Browser database: 2023 update","volume":"51","author":"Nassar","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib179","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.02.005_bib180","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: An R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.immuni.2026.02.005_bib187","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.immuni.2026.02.005_bib188","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib189","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2013.084","article-title":"De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis","volume":"8","author":"Haas","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib152","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib153","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.02.005_bib155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.02.005_bib161","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib158","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1093\/nar\/gku864","article-title":"Svaseq: Removing batch effects and other unwanted noise from sequencing data","volume":"42","author":"Leek","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib159","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The SVA package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib157","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1093\/bioinformatics\/btz247","article-title":"IsoformSwitchAnalyzeR: Analysis of changes in genome-wide patterns of alternative splicing and its functional consequences","volume":"35","author":"Vitting-Seerup","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib162","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: An R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.immuni.2026.02.005_bib190","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib191","article-title":"Thirteen years of clusterProfiler","volume":"5","author":"Yu","year":"2024","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.immuni.2026.02.005_bib160","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: A package for the generation of highly-customizable Venn and Euler diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.immuni.2026.02.005_bib192","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: An R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib193","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: Freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib194","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib195","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"Circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41592-019-0426-7","article-title":"Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning","volume":"16","author":"Gessulat","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2026.02.005_bib196","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/acs.jproteome.1c00096","article-title":"Universal Spectrum Explorer: A Standalone (Web-)Application for Cross-Resource Spectrum Comparison","volume":"20","author":"Schmidt","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib167","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/acs.jproteome.2c00834","article-title":"MSstats version 4.0: Statistical analyses of quantitative mass spectrometry-based proteomic experiments with chromatography-based quantification at scale","volume":"22","author":"Kohler","year":"2023","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib166","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2026.02.005_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.02.005_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib141","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J. Immunother."},{"key":"10.1016\/j.immuni.2026.02.005_bib144","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.02.005_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of Tumor Infiltrating Leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib148","doi-asserted-by":"crossref","first-page":"D1353","DOI":"10.1093\/nar\/gkac1046","article-title":"The next-generation Open Targets Platform: reimagined, redesigned, rebuilt","volume":"51","author":"Ochoa","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib149","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2011.431","article-title":"A transcription activator-like effector toolbox for genome engineering","volume":"7","author":"Sanjana","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2026.02.005_bib150","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2014.36","article-title":"Advanced methods of microscope control using \u03bcManager software","volume":"1","author":"Edelstein","year":"2014","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.immuni.2026.02.005_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114749","article-title":"FindFoci: A focus detection algorithm with automated parameter training that closely matches human assignments, reduces human inconsistencies and increases speed of analysis","volume":"9","author":"Herbert","year":"2014","journal-title":"PLOS One"},{"key":"10.1016\/j.immuni.2026.02.005_bib154","doi-asserted-by":"crossref","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","article-title":"GENCODE 2021","volume":"49","author":"Frankish","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib156","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.immuni.2026.02.005_bib163","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.immuni.2026.02.005_bib197","unstructured":"Yu, G. (2026). enrichplot: Visualization of Functional Enrichment Result. doi:10.18129\/B9.bioc.enrichplot, R package version 1.30.5, https:\/\/bioconductor.org\/packages\/enrichplot."},{"key":"10.1016\/j.immuni.2026.02.005_bib165","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/humu.23230","article-title":"HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data","volume":"38","author":"Kawaguchi","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.immuni.2026.02.005_bib168","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B"},{"key":"10.1016\/j.immuni.2026.02.005_bib169","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4939-8885-3_14","article-title":"Cancer exome-based identification of tumor neo-antigens using mass spectrometry","author":"Kalaora","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2026.02.005_bib170","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: A worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib171","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","article-title":"CD-HIT: Accelerated for clustering the next-generation sequencing data","volume":"28","author":"Fu","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2026.02.005_bib172","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The Immune Epitope Database (IEDB): 2024 Update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2026.02.005_bib173","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002071","article-title":"HLA Ligand Atlas: A benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy","volume":"9","author":"Marcu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.immuni.2026.02.005_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12441-w","article-title":"Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function","volume":"10","author":"Thomas","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.02.005_bib181","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: Software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:06:10Z","timestamp":1792094770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":195,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1074761326000750"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.02.005","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}